Literature DB >> 16492610

Determinants of hypertension control in a large French population of treated hypertensive subjects.

Olivier Roux1, Marion Chapellier, Sébastien Czernichow, Sophie Nisse-Durgeat, Michel E Safar, Jacques Blacher.   

Abstract

Only a minority of all hypertensives is well controlled in the population. In order to assess the proportion of well controlled hypertensives and the factors associated with hypertension control in France, we designed an observational cross-sectional epidemiological study in a population of 4702 treated adult hypertensives selected by general practitioners: EPISTRAT. This hypertensive treated population presented the following characteristics (mean+/-standard deviation): age: 60+/-12 years; blood pressure: 151+/-16/87+/-10 mmHg; men: 58%; body mass index: 27+/-5 kg/m2; diabetes mellitus: 12%; subjects in secondary cardiovascular prevention: 14%. Half of the patients presented two or more CV risk factors in addition to hypertension. Forty-eight per cent of the subjects were treated with antihypertensive monotherapy, 31% with bitherapy and 21% with more than two drugs. Patients with controlled hypertension (<140/90 mmHg) represented "only" 18% of the population. Multivariate analysis showed that male gender and advanced age were the two main variables independently associated with poor blood pressure control. Finally, the majority of patients experienced at least one antihypertensive treatment modification, mainly for insufficient therapeutic effect. In conclusion, this study has shown poor blood pressure control in a primary care-recruited population, especially in males and in the elderly.

Entities:  

Mesh:

Year:  2006        PMID: 16492610     DOI: 10.1080/08037050500450114

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  5 in total

Review 1.  Moving beyond guidelines: are report cards the answer to high rates of uncontrolled hypertension?

Authors:  Marcel Ruzicka; Frans H H Leenen
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 2.  Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.

Authors:  Bernard Waeber; François Feihl; Luis M Ruilope
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Efficacy and safety of irbesartan/HCTZ in severe hypertension according to cardiometabolic factors.

Authors:  Stanley S Franklin; Joel M Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-01       Impact factor: 3.738

4.  Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial.

Authors:  Jean-Jacques Mourad; Viet Nguyen; Marilucy Lopez-Sublet; Bernard Waeber
Journal:  Vasc Health Risk Manag       Date:  2007

5.  Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals.

Authors:  E K Chowdhury; A Owen; H Krum; L M H Wing; P Ryan; M R Nelson; C M Reid
Journal:  J Hum Hypertens       Date:  2013-02-28       Impact factor: 3.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.